Screener
Twist Bioscience Corporation TWST Accrued Manufacturing Costs
Accrued Manufacturing Costs at other companies
Other financials
Where this comes from
Reported directly by Twist Bioscience Corporation in its filing.
Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.
The source filing: Twist Bioscience Corporation’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 4:28 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001581280-26-000040
| (In thousands, except per share data) | March 31,2026 | September 30,2025 |
|---|---|---|
| Liabilities and stockholders’ equity | ||
| Current liabilities: | ||
| Accounts payable | $14,682 | $11,094 |
| Accrued compensation | 27,003 | 31,288 |
| Current portion of operating lease liability | 10,443 | 13,822 |
| Accrued expenses and other current liabilities | 67,848 | 35,202 |
| Total current liabilities | $119,976 | $91,406 |
| Operating lease liability, net of current portion | 85,398 | 61,750 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Twist Bioscience Corporation's accrued manufacturing costs?
- Twist Bioscience Corporation (TWST) reported accrued manufacturing costs of $27M in Q1 2026.
- How has Twist Bioscience Corporation's accrued manufacturing costs changed year-over-year?
- Twist Bioscience Corporation's accrued manufacturing costs increased by 8.4% year-over-year, from $24.92M to $27M.
- What is the long-term trend for Twist Bioscience Corporation's accrued manufacturing costs?
- Over 4 years (2021 to 2025), Twist Bioscience Corporation's accrued manufacturing costs has grown at a 8.8% compound annual growth rate (CAGR), from $22.33M to $31.29M.
Ask your AI about Twist Bioscience Corporation's accrued manufacturing costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude